Sionna Therapeutics, Inc. (SION) stock
SIONNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.07−0.05 (-1.60%)
Close on Nov 17, 2026Market cap $138.80MP/E –Yield –
Sionna Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Sionna Therapeutics's total assets was $263.26M at Sep 30, 2026. For fiscal 2025 it was $325.95M, up 75.5% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $325.95M | +75.5% |
| FY2024 | Dec 31, 2024 | $185.75M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $263.26M | -22.4% |
| Q2 FY2026 | Jun 30, 2026 | $283.25M | -19.5% |
| Q1 FY2026 | Mar 31, 2026 | $305.04M | -17.5% |
| Q4 FY2025 | Dec 31, 2025 | $325.95M | +75.5% |
| Q3 FY2025 | Sep 30, 2025 | $339.27M | – |
| Q2 FY2025 | Jun 30, 2025 | $352.05M | – |
| Q1 FY2025 | Mar 31, 2025 | $369.67M | – |
| Q4 FY2024 | Dec 31, 2024 | $185.75M | – |
See a number that looks wrong?